U.S. Communications Stock News

NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI Expands Oncology Portfolio With HRD-RNA And Lung Screening Deal

Tempus AI (NasdaqGS:TEM) has launched its HRD-RNA algorithm, designed to identify Homologous Recombination Deficiency in cancer using RNA data. The company also announced a partnership with Median Technologies to bring the eyonis LCS AI lung cancer screening tool to markets in the US and Europe. Tempus AI, which last closed at $55.41, is adding new tools to its precision oncology and early detection portfolio with the HRD-RNA algorithm and the eyonis LCS AI screening partnership. The stock...
NYSE:FDP
NYSE:FDPFood

Did Margin Gains and Capital Returns Just Shift Fresh Del Monte Produce's (FDP) Investment Narrative?

In February 2026, Fresh Del Monte Produce’s board declared a quarterly cash dividend of US$0.30 per share, payable on March 27 to shareholders of record as of March 4, and reported fourth-quarter 2025 sales of US$1,019.5 million with net income of US$31.9 million. The company coupled this dividend and earnings release with details of its completed share repurchase program and a sharper focus on core, higher-return categories that lifted quarterly profitability despite largely flat sales. Now...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Cognex Board Refresh Brings Automation And Sales Focus Into Spotlight

Cognex (NasdaqGS:CGNX) has added Dr. Sami Atiya and Chris Donato to its board of directors. Both bring leadership backgrounds from large technology and automation companies including ABB, Siemens, Zendesk and Oracle. Former CEO Robert Willett and one other long-serving director are set to retire from the board. Cognex, trading at $55.36, has seen strong recent share price moves, with the stock up 40.3% over the past 30 days and 49.9% year to date. Over the past year, shares are up 70.6%,...
NYSE:ACN
NYSE:ACNIT

US Stock Market Today S&P 500 Futures Ease As Housing And Factory Signals Diverge

The Morning Bull - US Market Morning Update Friday, Feb, 27 2026 US stock futures are pointing slightly lower this morning, with E-mini S&P 500 futures down about 0.2%, as investors weigh cheaper borrowing costs against mixed global growth signals. The 30 year US mortgage rate has dipped below 6% to 5.98%, which can make monthly payments a bit less painful and puts housing related names in focus. At the same time, the Kansas Fed Manufacturing Index has bounced to 10, a sign that factory...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

Should QuidelOrtho’s (QDEL) Lifotronic Immunoassay Expansion Require Action From QDEL Investors?

QuidelOrtho recently announced a long-term supply agreement with Lifotronic Technology to broaden its immunoassay analyzer platforms and add over 70 assays, including more than 25 not currently offered on its VITROS system, across select markets outside the United States. This collaboration could materially reshape QuidelOrtho’s international diagnostics offering by helping it compete for full‑menu tenders and better serve both small and high‑throughput laboratories. Next, we’ll examine how...
NYSE:U
NYSE:USoftware

Is Unity Software (U) Offering An Opportunity After Recent Share Price Weakness

If you are wondering whether Unity Software's share price still reflects its underlying worth, you are not alone. This article is set up to help you frame that question more clearly. Unity closed at US$19.58, with a 5.9% move over the last 7 days. The 30 day, year to date and 1 year returns of 52.5%, 55.8% and 25.2% declines highlight how sentiment has shifted over different timeframes. Recent news on Unity has focused on ongoing interest in its role as a key platform for real time 3D...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

Soleno Therapeutics Q4 Profitability Milestone Tests High P/E Narrative

Soleno Therapeutics (SLNO) just closed out FY 2025 with fourth quarter revenue of US$91.7 million and basic EPS of US$0.81, alongside net income of US$42.9 million. This capped a trailing 12 month line that shows revenue of US$190.4 million and basic EPS of US$0.40. The company reported revenue of US$66.0 million in Q3 and US$32.7 million in Q2, while EPS moved from US$0.49 in Q3 and a small loss in Q2. Together, these figures describe a story where higher sales and a cleaner income line are...
NYSE:DCO
NYSE:DCOAerospace & Defense

Ducommun (DCO) Swings Back To Quarterly Profit But Trailing Loss Tests Bullish Narratives

Ducommun (DCO) has wrapped up FY 2025 with fourth quarter revenue of US$215.8 million and basic EPS of US$0.50, alongside net income of US$7.4 million. The trailing twelve month figures show revenue of US$824.7 million and a net loss of US$33.9 million tied to basic EPS of US$2.27. Over recent quarters, revenue has moved from US$197.3 million in Q4 2024 to US$215.8 million in Q4 2025, with quarterly basic EPS ranging from a loss of US$4.30 in Q3 2025 to a profit of US$0.50 in Q4 2025. For...
NYSE:J
NYSE:JProfessional Services

Did Winning England’s Largest Ecosystem Survey Contract Just Shift Jacobs Solutions’ (J) Investment Narrative?

In February 2026, Natural England and Defra selected Jacobs Solutions to coordinate and deliver national-scale fieldwork for the England Ecosystem Survey, supporting collection of soil, vegetation and landscape data through to an expected conclusion in the first half of 2027. This role deepens Jacobs’ involvement in large-scale environmental policy infrastructure, aligning its consulting and program management capabilities with the U.K.’s Natural Capital and Ecosystem Assessment...
NYSE:SHAK
NYSE:SHAKHospitality

Shake Shack (SHAK) Margin Expansion Tests Bullish Growth Narrative After FY 2025 Results

Shake Shack (SHAK) has wrapped up FY 2025 with fourth quarter revenue of US$400.5 million and basic EPS of US$0.29, alongside trailing 12 month revenue of US$1.4 billion and EPS of US$1.14 that sit against very large reported earnings growth of 341.7% over the past year. The company has seen trailing 12 month revenue move from US$1.25 billion at the end of Q4 2024 to US$1.45 billion by Q4 2025, while trailing EPS stepped up from US$0.26 to US$1.14 and net profit margin shifted from 0.8% to...
NYSE:CMS
NYSE:CMSIntegrated Utilities

How New Board Appointments Shape CMS Energy's (CMS) Strategy on Grid Investment and Sustainability Oversight

Earlier this month, CMS Energy announced that retired Dominion Energy COO Diane Leopold and Meijer CEO Richard Keyes joined the CMS Energy and Consumers Energy boards, with Leopold assigned to the Compensation and Human Resources and Finance Committees and Keyes to the Audit and Governance, Sustainability and Public Responsibility Committees. The addition of a seasoned utility operator and a retail chief executive strengthens board oversight across capital allocation, executive pay, risk,...
NYSE:MMI
NYSE:MMIReal Estate

How Investors Are Reacting To Marcus & Millichap (MMI) Q4 Profit, Full-Year Loss and Buyback Completion

In February 2026, Marcus & Millichap, Inc. reported fourth-quarter 2025 revenue of US$243.95 million and net income of US$13.31 million, alongside full-year 2025 revenue of US$755.16 million and a net loss of US$1.91 million, while also disclosing that it completed a share repurchase program totaling 3,146,936 shares for US$98.00 million. These results show improved quarterly profitability and a smaller full-year loss compared with the prior year, while the completed buyback reduced the...
NYSE:GIC
NYSE:GICTrade Distributors

Is It Time To Reassess Global Industrial (GIC) After Its Strong 1 Year Share Price Run

Are you wondering if Global Industrial still offers good value after its recent run, or if the current price already reflects the key positives for the business? The stock last closed at US$33.26, with returns of 4.3% over 7 days, 9.9% over 30 days, 13.1% year to date, 48.4% over 1 year, 32.6% over 3 years and 10.4% over 5 years. This naturally raises questions about what is now priced in. Recent coverage has focused on Global Industrial's role as a distributor of industrial and business...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Explores Solriamfetol In Phase 3 CLARITY Trial For MDD Subset

Axsome Therapeutics (NasdaqGM: AXSM) has started the CLARITY Phase 3 trial of solriamfetol in major depressive disorder with excessive daytime sleepiness. The trial focuses on a group of MDD patients who experience excessive daytime sleepiness, for which no approved treatments are currently available. This study expands Axsome's clinical program into an area of unmet medical need. Axsome Therapeutics, listed on the NasdaqGM under the ticker AXSM, develops therapies for central nervous...
NYSE:SPXC
NYSE:SPXCMachinery

SPX Technologies Reshapes Business With Deals Earnings And Shifting Ownership

SPX Technologies is pursuing an acquisition-led expansion and investing heavily in capacity, including in data center infrastructure. The company recently reported record earnings that align with this repositioning of its business mix. At the same time, insider selling and shifts in institutional ownership are reshaping who holds NYSE:SPXC shares. For investors, this mix of corporate activity and ownership changes makes NYSE:SPXC a stock to watch. The shares recently closed at $231.59, with...
NasdaqGS:PZZA
NasdaqGS:PZZAHospitality

Papa Johns International PZZA Margin Compression Reinforces Bearish Cost Narrative In FY 2025 Results

Papa John's International FY 2025 Earnings Snapshot Papa John's International (PZZA) closed out FY 2025 with Q4 revenue of US$498.2 million and basic EPS of US$0.24, while trailing twelve month revenue came in at about US$2.1 billion with EPS of US$0.93. The company has seen quarterly revenue move from US$530.8 million in Q4 2024 to US$498.2 million in Q4 2025, with basic EPS shifting from US$0.45 to US$0.24 over the same period, and trailing net income excluding extra items sitting at...
NYSE:MCB
NYSE:MCBBanks

A Look At Metropolitan Bank Holding (MCB) Valuation After Recent Follow On Equity Offerings

Metropolitan Bank Holding (MCB) has completed and filed follow-on equity offerings totaling roughly US$353.5 million, issuing 2,100,000 common shares at US$85, a move that directly affects existing and prospective shareholders. See our latest analysis for Metropolitan Bank Holding. The follow on offerings come after a strong 1 year total shareholder return of 41.92% and a 3 year total shareholder return of 56.43%. However, recent momentum has cooled, with a 7 day share price return showing an...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Is It Time To Reassess Natera (NTRA) After Strong Multi Year Share Price Gains

If you are wondering whether Natera's current share price reflects its real value, you are not alone. This article will help you frame that question clearly. Natera's share price last closed at US$216.10, with a 7 day return of 0.1% decline, a 30 day return of 10.1% decline, a year to date return of 5.6% decline, and a 1 year return of 38.0%, alongside a very large 3 year return and a 111.6% return over 5 years. Recent headlines around Natera have kept the stock on many investors'...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Magnite (MGNI) Net Margin Surge Challenges Bearish Earnings Narratives

Magnite (MGNI) closed out FY 2025 with Q4 revenue of US$205.4 million and basic EPS of US$0.86, capped by trailing 12 month EPS of US$1.01 that sits on trailing 12 month revenue of US$714.0 million. Over the past six quarters in this dataset, revenue has moved from US$162.0 million in Q3 2024 to US$205.4 million in Q4 2025, while quarterly EPS shifted from US$0.04 to US$0.86, creating a backdrop where margins have become a central focus for investors assessing the latest print. See our full...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

What Futu Holdings (FUTU)'s Q4 2025 Results and Education Push Mean For Shareholders

Earlier in 2026, Futu Holdings announced that it would report its fourth-quarter and full-year 2025 results on March 12, 2026, before U.S. markets open, accompanied by a management earnings call and webcast. Alongside its earnings timetable, Futu’s moomoo platform has been promoting financial education through initiatives like the Student Stock Showdown, underscoring how its brokerage technology is also being used to build investing literacy among younger users. With stronger recent earnings...
NYSE:WSO
NYSE:WSOTrade Distributors

Dividend Hike Amid Softer Earnings Might Change The Case For Investing In Watsco (WSO)

In February 2026, Watsco, Inc. reported that its fourth-quarter 2025 sales fell to US$1,578.76 million and net income to US$71.75 million, and also approved a 10% increase in its annual dividend to US$13.20 per share for both Common and Class B shares. The combination of softer recent earnings and a higher dividend, underpinned by management’s emphasis on improved gross margins and a debt-free balance sheet, highlights how Watsco is prioritizing shareholder returns while contending with...
NYSE:BAP
NYSE:BAPBanks

Is It Time To Reassess Credicorp (NYSE:BAP) After Its Strong Multi Year Share Price Run?

If you are looking at Credicorp and wondering whether the current share price still reflects solid value, you are not alone. This article will walk through what the numbers actually say. The stock last closed at US$355.48, with returns of 1.7% over 7 days, a marginal 0.2% decline over 30 days, 24.1% year to date, 106.7% over 1 year and 183.7% over 5 years. This naturally raises questions about how much future upside or risk is already built in. Recent news coverage has focused on Credicorp's...
NYSE:ARLO
NYSE:ARLOElectronic

A Look At Arlo Technologies (ARLO) Valuation After Recent Share Price Volatility

Arlo Technologies (ARLO) has drawn fresh attention after recent trading left the stock up 3.6% over the past week, but down over the past month and past 3 months, prompting closer scrutiny from investors. See our latest analysis for Arlo Technologies. That recent 6.2% 7 day share price return comes after weaker momentum earlier in the year, with a 30 day share price return of 6.52% and year to date share price return of 6.73%. The 3 year total shareholder return is roughly 3.3x, which hints...
NasdaqGS:PCTY
NasdaqGS:PCTYProfessional Services

A Look At Paylocity (PCTY) Valuation After Q2 Beat And Raised 2026 Revenue Outlook

Paylocity Holding (PCTY) is in focus after second quarter results came in ahead of guidance, prompting higher revenue projections for fiscal 2026 and an updated outlook for total and recurring revenues. See our latest analysis for Paylocity Holding. The second quarter beat and upgraded fiscal 2026 revenue outlook arrive after a mixed share price run, with an 8.52% 1 day share price return and 6.59% 7 day share price return contrasting with a 19.95% 30 day share price decline and a 44.87% 1...